Send me real-time posts from this site at my email

Why Valeant's Private Offering Upsize is Good News

* Valeant $VRX once again shows there is high demand for Bausch Health bonds.
* This shifts maturities of 2020 and 2021 to the 2027 year
* Near-term credit risks reduced
* Threat of bankruptcy diminished once again.

Related: Generics are back in favor. $TEVA, $ENDP are recovering.

$TEVA, Teva Pharmaceutical Industries Limited American Depositary Shares / H1


$ENDP, Endo International plc - Ordinary Shares / H1